DC Bead
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DC Bead, covering 2012-09-24 to 2012-09-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC). [Phase 2]